// App-Quantinova.ai

PB0525 : Inter-Centre and Inter-Observer Agreement of Determination of DOACs in Urine Samples of Patients by Means of DOAC Dipstick Test

Researchers

Presenter

  • J. Harenberg

Principal Investigators

  • R. Bauersachs

  • J. Beyer Westendorf

  • M. Crowther

  • J. Douxfils

  • I. Elalamy

  • S. Hetjens

  • P. Verhamme

  • C. Weiss

Medical Centers

  • Doasense GmbH, Heidelberg, Germany

  • Heidelberg University Hospital, Heidelberg, Germany

  • Klinikum Darmstadt GmbH, Department of Vascular Medicine, Darmstadt, Germany

  • University Hospital 'Carl Gustav Carus', Department of Medicine I, Division Hematology, Dresden, Germany

  • King's College Hospital, Department of Rheumatology, London, London, United Kingdom

  • McMaster University, Hamilton, Department of Medicine, Thrombosis and Atherosclerosis Research Institute, Hamilton, Canada

  • University of Namur, Department of Pharmacy, Namur Thrombosis and Hemostasis Centre, Namur, Belgium

  • Qualiblood s.a., Namur, Belgium

  • Hôpital Tenon, Hôpitaux Universitaires Est Parisien, Assistance Publique Hôpitaux de Paris (AP‐HP), Service d'Hématologie Biologique, Paris, France

  • The First I.M. Sechenov Moscow State Medical University, Obstetrics & Gynaecology, Moscow, Russian Federation

  • Heidelberg University, Department of Statistics, Medical Faculty Mannheim, Mannheim, Germany

  • KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium

Locations

  • Germany

  • United Kingdom

  • Canada

  • Belgium

  • France

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • apixaban

  • Evithrom

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multinational

  • Multicenteric

  • Prospective

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved